These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 29769973)

  • 1. Regulatory oversight of human pathogens and toxins in Canada.
    Labrie C; Lecordier S
    Can Commun Dis Rep; 2015 Dec; 41(Suppl 6):14-18. PubMed ID: 29769973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance of laboratory exposures to human pathogens and toxins: Canada 2016.
    Bienek A; Heisz M; Su M
    Can Commun Dis Rep; 2017 Nov; 43(11):228-235. PubMed ID: 29770052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance of laboratory exposures to human pathogens and toxins: Canada 2017.
    Pomerleau-Normandin D; Heisz M; Tanguay F
    Can Commun Dis Rep; 2018 Nov; 44(11):297-304. PubMed ID: 30996692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baby doe redux? The Department of Health and Human Services and the Born-Alive Infants Protection Act of 2002: a cautionary note on normative neonatal practice.
    Sayeed SA
    Pediatrics; 2005 Oct; 116(4):e576-85. PubMed ID: 16199687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canada's
    Bubela T; Kleiderman E; Master Z; Ogbogu U; Ravitsky V; Zarzeczny A; Knoppers BM
    Front Med (Lausanne); 2019; 6():157. PubMed ID: 31355201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective doses, guidelines & regulations.
    Burch MD
    Adv Exp Med Biol; 2008; 619():831-53. PubMed ID: 18461792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation and oversight of independent health facilities in Canada.
    Pries CR; Vanin S; Cartagena RG
    Health Law Can; 2014 Feb; 34(3):61-91. PubMed ID: 24696939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of Restricted Experiment Requests, Division of Select Agents and Toxins, Centers for Disease Control and Prevention, 2006-2013.
    Smith J; Gangadharan D; Weyant R
    Health Secur; 2015; 13(5):307-16. PubMed ID: 26347984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic approach towards establishing a National Inventory of Dangerous Pathogens.
    Vennis IM; Bleijs DA; Brizee S; Van Den Berg HHJL; Kampert E; Rutjes SA; Van Passel MWJ
    Glob Health Action; 2021 Jan; 14(1):1971866. PubMed ID: 34493169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory Framework for Conducting Clinical Research in Canada.
    Alas JK; Godlovitch G; Mohan CM; Jelinski SA; Khan AA
    Can J Neurol Sci; 2017 Sep; 44(5):469-474. PubMed ID: 28862104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the Canadian and US Laws, Regulations, Policies, and Systems of Oversight for Animals in Research.
    Griffin G; Locke P
    ILAR J; 2016 May; 57(3):271-284. PubMed ID: 29117406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hidden face of academic researches on classified highly pathogenic microorganisms.
    Devaux CA
    Infect Genet Evol; 2015 Jan; 29():26-34. PubMed ID: 25445654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possession, Use, and Transfer of Select Agents and Toxins; Biennial Review of the List of Select Agents and Toxins and Enhanced Biosafety Requirements. Final rule.
    Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS)
    Fed Regist; 2017 Jan; 82(12):6278-94. PubMed ID: 28106357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human-nonhuman chimeras: a regulatory proposal on the blurring of species lines.
    Kopinksi NE
    Boston Coll Law Rev; 2004 May; 45(3):619-66. PubMed ID: 16514749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing corporate standing, shifting blame: An examination of Canada's Extractive Sector Transparency Measures Act.
    Ciupa K; Zalik A
    Extr Ind Soc; 2020 Jul; 7(3):826-834. PubMed ID: 32837933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canada: will privacy rules continue to favour open science?
    Thorogood A
    Hum Genet; 2018 Aug; 137(8):595-602. PubMed ID: 30014188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poster - Thur Eve - 02: Regulatory oversight of the robotic radiosurgery facilities.
    Broda K
    Med Phys; 2012 Jul; 39(7Part2):4624. PubMed ID: 28516564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human pathogens importation regulations. Department of National Health and Welfare.
    Can J Med Technol; 1993; 55(1):59-63. PubMed ID: 10124401
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.